ES2061652T3 - Polipeptidos que contienen homocicloestatina y cicloestatina como agentes antihipertensivos. - Google Patents

Polipeptidos que contienen homocicloestatina y cicloestatina como agentes antihipertensivos.

Info

Publication number
ES2061652T3
ES2061652T3 ES88305847T ES88305847T ES2061652T3 ES 2061652 T3 ES2061652 T3 ES 2061652T3 ES 88305847 T ES88305847 T ES 88305847T ES 88305847 T ES88305847 T ES 88305847T ES 2061652 T3 ES2061652 T3 ES 2061652T3
Authority
ES
Spain
Prior art keywords
homocycloestatine
cyclostatic
polypeptides containing
hypertensive agents
polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88305847T
Other languages
English (en)
Inventor
Dennis Jay Hoover
Robert Louis Rosati
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Application granted granted Critical
Publication of ES2061652T3 publication Critical patent/ES2061652T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0227—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the (partial) peptide sequence -Phe-His-NH-(X)2-C(=0)-, e.g. Renin-inhibitors with n = 2 - 6; for n > 6 see C07K5/06 - C07K5/10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

POLIPEPTIDOS Y SUS DERIVADOS, QUE CONTIENEN HOMOCICLOESTATINA Y CICLOESTATINA, SON UTILES PARA INHIBIR LA ACCION DE EXCISION DE ANGIOTENSINOGENO DEL ENZIMA RENINA.
ES88305847T 1987-07-01 1988-06-24 Polipeptidos que contienen homocicloestatina y cicloestatina como agentes antihipertensivos. Expired - Lifetime ES2061652T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6899287A 1987-07-01 1987-07-01

Publications (1)

Publication Number Publication Date
ES2061652T3 true ES2061652T3 (es) 1994-12-16

Family

ID=22086011

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88305847T Expired - Lifetime ES2061652T3 (es) 1987-07-01 1988-06-24 Polipeptidos que contienen homocicloestatina y cicloestatina como agentes antihipertensivos.

Country Status (10)

Country Link
EP (1) EP0297816B1 (es)
JP (1) JPH0631313B2 (es)
AT (1) ATE102214T1 (es)
CA (1) CA1321676C (es)
DE (1) DE3888031T2 (es)
DK (1) DK362288A (es)
ES (1) ES2061652T3 (es)
FI (1) FI883135A (es)
IE (1) IE61842B1 (es)
PT (1) PT87868B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3902615A1 (de) * 1988-08-27 1990-03-08 Bayer Ag Aminomethyl-peptide, verfahren zur herstellung und ihre verwendung in arzneimitteln
IE70080B1 (en) * 1989-02-16 1996-10-30 Sankyo Co Peptides having renin inhibitory activity their preparation and use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0184855A3 (en) * 1984-12-14 1989-05-03 Abbott Laboratories Resin inhibiting compounds
US4729985A (en) * 1985-08-09 1988-03-08 Pfizer Inc. Renin inhibitors containing 5-amino-2,5-disubstituted-4-hydroxypentanoic acid residues
DE3538749A1 (de) * 1985-10-31 1987-05-07 Merck Patent Gmbh Peptide
EP0314239A3 (en) * 1987-10-28 1990-12-27 Merck & Co. Inc. Tripeptide renin inhibitors with n-terminal ureido or sulfamido groups

Also Published As

Publication number Publication date
DK362288D0 (da) 1988-06-30
PT87868A (pt) 1989-06-30
CA1321676C (en) 1993-08-24
ATE102214T1 (de) 1994-03-15
DK362288A (da) 1989-02-24
DE3888031D1 (de) 1994-04-07
JPH0631313B2 (ja) 1994-04-27
JPS6426596A (en) 1989-01-27
DE3888031T2 (de) 1994-06-09
EP0297816A2 (en) 1989-01-04
EP0297816B1 (en) 1994-03-02
PT87868B (pt) 1995-03-01
FI883135A (fi) 1989-01-02
IE61842B1 (en) 1994-11-30
FI883135A0 (fi) 1988-06-30
IE881991L (en) 1989-01-01
EP0297816A3 (en) 1990-09-05

Similar Documents

Publication Publication Date Title
MY103189A (en) Nor-statine and nor-cyclostatine polypeptides
ES2001056A6 (es) Un procedimiento para la preparacion de polipeptidos y sus derivados que contienen oxa- y azahomocicloestatina.
DK172089D0 (da) 1,3-dioxolanderivater samt fremgangsmaade til fremstilling deraf
MX9302932A (es) Nuevas 4-aza-5&-androstan-3-onas 7b-substituidas como inhibidores de la5&-reductasa.
MX9302931A (es) Nuevas 4-aza-5&-colestan-onas 7b-substituidas como inhibidores de 5&-reductasa.
DE3869007D1 (de) Oxydation von alkanen.
PT87618A (pt) Process for the preparation of polymeric hinderd amine light stabilizers and organic compositions therewith
ES2051695T3 (es) Tratamiento de la trombosis que contiene un fibrinolitico y un analogo de carbaciclina.
DK490486A (da) Sammensaetning til behandling af atherosclerose, tromboser og/eller perifere karsygdomme
DE3855293D1 (de) Gemisch zum Stabilisieren von Polyurethanen
ES2042726T3 (es) Beta-alquilmelatoninas.
ES2075014T3 (es) Derivados de progesterona 19-sustituidos utiles como inhibidores de 19-hidroxilasa.
DK187589A (da) Hurtigtvirkende prourokinase
ES2061652T3 (es) Polipeptidos que contienen homocicloestatina y cicloestatina como agentes antihipertensivos.
DK491988A (da) Modificerede plasminogen-aktivatorer
DK221488A (da) Garvemidler samt fremgangsmaade til garvning
DK221388D0 (da) Garvemiddel samt fremgangsmaade til garvning
DE3855157D1 (de) Verstärkerschaltungsanordnung
ATA238587A (de) Anordnung zur einbringung von strahlenquellen
HK164696A (en) Bipolar transistor amplifier
DE3851257D1 (de) Azyliertes Derivat von Superoxid-Dismutase und dieses enthaltende Zusammensetzung.
NO874017D0 (no) Verktoey for legging av gulvbord og parkett.
MX9203408A (es) Compuestos antihipertensivos de mercapto-acilaminoacido.
NO932412D0 (no) Fremgangsmaate for aa inaktivere exonuklease-aktivitet
SU1543920A1 (ru) Электропневмогидравлический усилитель

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 297816

Country of ref document: ES